Telesis Bio, Inc. (TBIO)
USD 0.43
(50.88%)
USD 0.43
(50.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -34.66 Million | -38.71 Million | -36.69 Million | -15.38 Million | -6.39 Million | -22.13 Million |
| Net Income | -47.72 Million | -48.47 Million | -38.95 Million | -18.01 Million | -8.3 Million | -97.39 Million |
| Depreciation & Amortization | 4.1 Million | 2.87 Million | 1.57 Million | 1.45 Million | 857 Thousand | 2.84 Million |
| Deferred income taxes | -18.6 Million | - | 2.3 Million | 443 Thousand | -486 Thousand | -5.56 Million |
| Stock-based compensation | 3.96 Million | 3.72 Million | 1.08 Million | 43 Thousand | 13.2 Thousand | - |
| Change in working capital | -7.76 Million | 2.13 Million | -3.03 Million | -20 Thousand | 225 Thousand | 84.36 Million |
| Other non-cash items | 31.36 Million | 1.02 Million | 333 Thousand | 706 Thousand | 2.44 Million | -13.71 Million |
| Investing Cash Flow | -5.74 Million | -18 Million | -15.04 Million | -204 Thousand | -79 Thousand | -85.29 Million |
| Investments in PPE | -1.98 Million | -4.46 Million | -1.85 Million | -204 Thousand | -79 Thousand | -6.58 Million |
| Acquisitions | 16 Thousand | -556 Thousand | -13.18 Million | - | - | - |
| Investment purchases | -33.77 Million | -77.42 Million | - | - | -174.27 Million | -136.69 Million |
| Sales/Maturities of investments | 29.99 Million | 64.44 Million | - | - | 159.62 Million | 57.98 Million |
| Other Investing Activities | -3.76 Million | -556 Thousand | - | - | 14.64 Million | - |
| Financing Cash Flow | 11.56 Million | 4.51 Million | 121.08 Million | -96 Thousand | 35.1 Million | 113.62 Million |
| Debt repayment | -15.09 Million | -15.07 Million | -5.08 Million | -107 Thousand | -2.26 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 26.65 Million | 528 Thousand | 112.48 Million | 11 Thousand | 32.95 Million | 117.44 Million |
| Other Financing Activities | 26.65 Million | 19.06 Million | 13.67 Million | 11 Thousand | -113 Thousand | -3.82 Million |
| Accounts receivables | -1.33 Million | -2.18 Million | -735 Thousand | -774 Thousand | -859 Thousand | - |
| Accounts payables | -3.28 Million | 1.16 Million | -298 Thousand | 142 Thousand | 232 Thousand | 658 Thousand |
| Inventory | -1.82 Million | 168 Thousand | -1.46 Million | 111 Thousand | 723 Thousand | - |
| Other working capital | -1.32 Million | 2.98 Million | -542 Thousand | 501 Thousand | 129 Thousand | 83.7 Million |
| Cash at beginning of period | 30.59 Million | 82.8 Million | 13.46 Million | 29.14 Million | 56.22 Million | 50.02 Million |
| Cash at end of period | 1.74 Million | 30.59 Million | 82.8 Million | 13.46 Million | 29.14 Million | 56.22 Million |
| Capital Expenditure | -1.98 Million | -4.46 Million | -1.85 Million | -204 Thousand | -79 Thousand | -6.58 Million |
| Effect of forex changes on cash | -3000.00 | - | - | - | 669 Thousand | - |
| Net cash flow / Change in cash | -28.84 Million | -52.21 Million | 69.34 Million | -15.68 Million | -27.08 Million | 6.2 Million |
| Free Cash Flow | -36.64 Million | -43.18 Million | -38.55 Million | -15.58 Million | -6.46 Million | -28.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.56 Million | -8.63 Million | -17.68 Million | -47.72 Million | -10.63 Million | -8.28 Million |
| Depreciation & Amortization | 806 Thousand | 1.17 Million | 1.15 Million | 4.1 Million | 854 Thousand | 958 Thousand |
| Deferred income taxes | - | - | -6.19 Million | -18.6 Million | -130 Thousand | -58 Thousand |
| Stock-based compensation | 869 Thousand | 766 Thousand | 616 Thousand | 3.96 Million | 1.15 Million | 1.03 Million |
| Change in working capital | 2.21 Million | 3.38 Million | -3.89 Million | -7.76 Million | 2.37 Million | -4.05 Million |
| Other non-cash items | 3.19 Million | 467 Thousand | 18.7 Million | 31.36 Million | 484 Thousand | 111 Thousand |
| Investing Cash Flow | 1.12 Million | 12.24 Million | 6.49 Million | -5.74 Million | -23.2 Million | 6.84 Million |
| Investments in PPE | -81 Thousand | -502 Thousand | -252 Thousand | -1.98 Million | -104 Thousand | -1.15 Million |
| Acquisitions | - | - | - | 16 Thousand | 16 Thousand | - |
| Investment purchases | -4.58 Million | - | - | -33.77 Million | -26.61 Million | - |
| Sales/Maturities of investments | 5.8 Million | 12.75 Million | 6.74 Million | 29.99 Million | 3.49 Million | 8 Million |
| Other Investing Activities | -6000.00 | 12.75 Million | 6.74 Million | -3.76 Million | -23.1 Million | 8 Million |
| Financing Cash Flow | -7000.00 | -27 Thousand | -15.02 Million | 11.56 Million | -101 Thousand | 26.7 Million |
| Debt repayment | -19 Thousand | -19 Thousand | -15.05 Million | -15.09 Million | -11 Thousand | -1000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12 Thousand | 4000.00 | 26.57 Million | 26.65 Million | 25 Thousand | 46 Thousand |
| Other Financing Activities | 12 Thousand | -12 Thousand | -26.54 Million | 26.65 Million | -115 Thousand | 26.66 Million |
| Accounts receivables | 906 Thousand | 2.96 Million | -1.82 Million | -1.33 Million | 2.88 Million | -2.4 Million |
| Accounts payables | 447 Thousand | -598 Thousand | -1.7 Million | -3.28 Million | 931 Thousand | 700 Thousand |
| Inventory | 260 Thousand | 356 Thousand | 245 Thousand | -1.82 Million | -409 Thousand | -1.56 Million |
| Other working capital | 600 Thousand | 662 Thousand | -617 Thousand | -1.32 Million | -1.02 Million | -787 Thousand |
| Cash at beginning of period | 10.72 Million | 1.74 Million | 17.57 Million | 30.59 Million | 46.78 Million | 23.53 Million |
| Cash at end of period | 6.49 Million | 10.72 Million | 1.74 Million | 1.74 Million | 17.57 Million | 46.78 Million |
| Capital Expenditure | -81 Thousand | -502 Thousand | -252 Thousand | -1.98 Million | -104 Thousand | -1.15 Million |
| Effect of forex changes on cash | - | -6000.00 | 13 Thousand | -3000.00 | -16 Thousand | - |
| Net cash flow / Change in cash | -4.22 Million | 8.97 Million | -15.82 Million | -28.84 Million | -29.21 Million | 23.25 Million |
| Free Cash Flow | -5.42 Million | -3.73 Million | -7.56 Million | -36.64 Million | -5.99 Million | -11.45 Million |
URI
2169
DOTD
ATIF
FNTL
NEO